Cargando…
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview
Patients with hepatocellular carcinoma (HCC) face a common type of cancer, which is amongst the most deadly types of cancer worldwide. The therapeutic options range from curative resection or ablation to loco regional therapies in palliative setting and last but not least, systemic treatment. The la...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821931/ https://www.ncbi.nlm.nih.gov/pubmed/33374927 http://dx.doi.org/10.3390/ph14010003 |